Bauer Jake has filed 12 insider transactions across 3 companies since February 2023.
Most recent transaction: a grant/award of 7061 shares of Immunovant, Inc. ($IMVT) on April 07, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 7, 2026 | Immunovant, Inc. | $IMVT | Bauer Jake | Director | A | Stock Option (right to buy) | 7061 | $0.00 | 7,061.0000 | 203,532,180 | 9999.99% | 0.00% |
| April 7, 2026 | Immunovant, Inc. | $IMVT | Bauer Jake | Director | A | Common Stock | 13880 | $0.00 | 38,896.0000 | 203,532,180 | 55.48% | 0.01% |
| Feb. 12, 2026 | Enliven Therapeutics, Inc. | $ELVN | Bauer Jake | Not found | A | Stock Option (right to buy) | 17126 | $0.00 | 17,126.0000 | 62,093,795 | 9999.99% | 0.03% |
| Aug. 26, 2025 | BridgeBio Oncology Therapeutics, Inc. | $BBOT | Bauer Jake | Not found | A | Stock Option (Right to Buy) | 138193 | $0.00 | 138,193.0000 | 0 | 9999.99% | 0.00% |
| May 1, 2025 | Immunovant, Inc. | $IMVT | Bauer Jake | Not found | A | Common Stock | 25016 | $0.00 | 25,016.0000 | 0 | 9999.99% | 0.00% |
| May 1, 2025 | Immunovant, Inc. | $IMVT | Bauer Jake | Not found | A | Stock Option (Right to Buy) | 35234 | $0.00 | 35,234.0000 | 0 | 9999.99% | 0.00% |
| Feb. 6, 2025 | Enliven Therapeutics, Inc. | $ELVN | Bauer Jake | Not found | A | Stock Option (right to buy) | 20491 | $0.00 | 20,491.0000 | 47,072,532 | 9999.99% | 0.04% |
| Feb. 13, 2024 | Enliven Therapeutics, Inc. | $ELVN | Bauer Jake | Not found | A | Stock Option (right to buy) | 23364 | $0.00 | 23,364.0000 | 35,546,215 | 9999.99% | 0.07% |
| Feb. 13, 2024 | Enliven Therapeutics, Inc. | $ELVN | Bauer Jake | Not found | A | Stock Option (right to buy) | 16835 | $0.00 | 16,835.0000 | 35,546,215 | 9999.99% | 0.05% |
| Feb. 23, 2023 | Enliven Therapeutics, Inc. | $ELVN | Bauer Jake | Director | A | Stock Option (right to buy) | 27567 | $0.00 | 27,567.0000 | 0 | 9999.99% | 0.00% |
| Feb. 23, 2023 | Enliven Therapeutics, Inc. | $ELVN | Bauer Jake | Director | A | Stock Option | 17706 | $0.00 | 17,706.0000 | 0 | 9999.99% | 0.00% |
| Feb. 23, 2023 | Enliven Therapeutics, Inc. | $ELVN | Bauer Jake | Director | A | Common Stock | 87372 | $0.00 | 87,372.0000 | 0 | 9999.99% | 0.00% |